Daniel L. Parsons

Affiliations: 
Auburn University, Auburn, AL, United States 
Area:
Pharmacy, Pharmaceutical Chemistry
Google:
"Daniel Parsons"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Sathigari SK, Radhakrishnan VK, Davis VA, et al. (2012) Amorphous-state characterization of efavirenz--polymer hot-melt extrusion systems for dissolution enhancement. Journal of Pharmaceutical Sciences. 101: 3456-64
Kolli CS, Xiao J, Parsons DL, et al. (2012) Microneedle assisted iontophoretic transdermal delivery of prochlorperazine edisylate. Drug Development and Industrial Pharmacy. 38: 571-6
Chadha G, Sathigari S, Parsons DL, et al. (2011) In vitro percutaneous absorption of genistein from topical gels through human skin. Drug Development and Industrial Pharmacy. 37: 498-505
Kolli CS, Chadha G, Xiao J, et al. (2010) Transdermal iontophoretic delivery of selegiline hydrochloride, in vitro. Journal of Drug Targeting. 18: 657-64
Phillip Lee YH, Sathigari S, Jean Lin YJ, et al. (2009) Gefitinib-cyclodextrin inclusion complexes: physico-chemical characterization and dissolution studies. Drug Development and Industrial Pharmacy. 35: 1113-20
Jayachandra Babu R, Ravis WR, Duran SH, et al. (2009) Enhancement of transdermal delivery of phenylbutazone from liposomal gel formulations through deer skin. Journal of Veterinary Pharmacology and Therapeutics. 32: 388-92
Sathigari S, Chadha G, Lee YH, et al. (2009) Physicochemical characterization of efavirenz-cyclodextrin inclusion complexes. Aaps Pharmscitech. 10: 81-7
Zhang L, Parsons DL, Navarre C, et al. (2002) Development and in-vitro evaluation of sustained release poloxamer 407 (P407) gel formulations of ceftiofur. Journal of Controlled Release : Official Journal of the Controlled Release Society. 85: 73-81
Shah IG, Parsons DL. (1992) Human albumin binding of tamoxifen in the presence of a perfluorochemical erythrocyte substitute. The Journal of Pharmacy and Pharmacology. 43: 790-3
Ravis WR, Hoke JF, Parsons DL. (1991) Perfluorochemical erythrocyte substitutes: disposition and effects on drug distribution and elimination. Drug Metabolism Reviews. 23: 375-411
See more...